100 Most Influential People in Healthcare - 2017

• Compensation: $1,100,000

• Years on list: 2

Ubl took the reins of the Pharmaceutical Research and Manufacturers of America in September 2015 just as public outrage over spiking prescription drug prices was making national headlines. A nimble inside-the-Beltway operative, he came to PhRMA from the Advanced Medical Technology Association, or AdvaMed, the trade group for medical-device makers, where he won a two-year reprieve from the Affordable Care Act's device tax. Ubl is trying to educate policymakers on both the marketplace dynamics as well as the value the products bring to patient care and healthcare systems.